Cell Robotics has CE-marked the Personal Lasette, the smaller, less expensive version of its product for less painful extraction of blood for glucose testing. The new generation of laser finger perforator is slightly larger than a mobile phone and weighs approximately 0.2 kg.
Cell Robotics CE-marks Personal Lasette:
Cell Robotics has CE-marked the Personal Lasette, the smaller, less expensive version of its product for less painful extraction of blood for glucose testing. The new generation of laser finger perforator is slightly larger than a mobile phone and weighs approximately 0.2 kg.
More from Archive
More from Medtech Insight
Now that a federal judge has ruled the US FDA exceeded its authority by unilaterally assuming regulatory oversight of lab-developed tests, what’s the agency’s next move? And does it really have one?
Health tech is at the forefront of the women's health sector, securing 38% of venture capital in 2024. However, panelists at the Anglonordic Life Science Conference held 3 April asserted that a successful therapeutic breakthrough is key to gaining investor confidence and accelerating venture capital.
The UK’s “New Approach” to regulation has created a lot of noise, but what’s the end product? asks Taylor Wessing partner Alison Dennis, who says the UK medtech regulator should look afresh at the EU’s ready-made solution.